Logo-ipp

Review

1. High risk individuals in COVID-19 pandemic; an updated review
Rojin Chegini ORCID, Alireza Bolurian ORCID, Zahra Mojtahedi ORCID, Masoud Hafizi* ORCID
Immunopathol Persa. 2021;7(2): e25. doi: 10.34172/ipp.2021.25
Scopus ID: 85102568029    
Article
PDF
XML
Cited By:
2
1

Original

2. The severity of symptoms and outcomes of patients admitted with rheumatic diseases and COVID-19; a prospective cohort study in Iran
Mansour Salesi ORCID, Ramin Sami ORCID, Somayeh Haji Ahmadi ORCID, Nilufar Khademi ORCID, Mehrnegar Dehghan ORCID, Soheila Jalali ORCID, Marjan Mansourian ORCID, Huriyeh Hashemi* ORCID
Immunopathol Persa. 2021;7(2): e34. doi: 10.34172/ipp.2021.34
Scopus ID: 85112513490    
Article
PDF
XML
Cited By:
1
1
Review

3. A systematic review and meta-analysis on the association between lymphocyte subsets and the severity of COVID-19
Hojat Dehghanbanadaki ORCID, Hossein Aazami ORCID, Mahya Shabani ORCID, Dorsa Amighi, Farhad Seif ORCID, Ali Zare Dehnavi ORCID, Abdolkarim Hajighadery ORCID, Mohammad-Mehdi Mehrabi Nejad ORCID, Mohammad Ghafouri ORCID, Nima Hajizadeh ORCID, Fateme Abedin ORCID, Zahra Hajizadeh ORCID, Mehrdad Heravi ORCID, Parsa Panahi ORCID, Ali Kabir* ORCID
Immunopathol Persa. 2022;8(2): e29303. doi: 10.34172/ipp.2022.29303
Scopus ID: 85133629380    
Article
PDF
XML
Cited By:
1
0

Original Article

4. Clinical signs, symptoms, and severity of COVID-19 in patients with rheumatic diseases during the COVID-19 epidemic

Mansour Salesi, Maryam Sedarat* ORCID
Immunopathol Persa. 2024;10(1): e40568. doi: 10.34172/ipp.2023.40568
Article
PDF
XML
Cited By: